Universal Beteiligungs und Servicegesellschaft mbH Has $13.17 Million Holdings in Encompass Health Corporation $EHC

Universal Beteiligungs und Servicegesellschaft mbH trimmed its position in Encompass Health Corporation (NYSE:EHC) by 10.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 107,422 shares of the company’s stock after selling 12,689 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Encompass Health were worth $13,173,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. IFP Advisors Inc raised its position in Encompass Health by 5.9% in the first quarter. IFP Advisors Inc now owns 2,814 shares of the company’s stock valued at $285,000 after purchasing an additional 158 shares during the last quarter. Allianz Asset Management GmbH increased its stake in shares of Encompass Health by 42.4% in the first quarter. Allianz Asset Management GmbH now owns 396,649 shares of the company’s stock valued at $40,173,000 after buying an additional 118,056 shares during the period. Y Intercept Hong Kong Ltd bought a new position in Encompass Health in the 1st quarter valued at approximately $505,000. KLP Kapitalforvaltning AS boosted its position in Encompass Health by 2.0% during the 1st quarter. KLP Kapitalforvaltning AS now owns 20,900 shares of the company’s stock worth $2,117,000 after buying an additional 400 shares during the period. Finally, Avantax Advisory Services Inc. grew its holdings in Encompass Health by 2.3% during the 1st quarter. Avantax Advisory Services Inc. now owns 10,054 shares of the company’s stock worth $1,018,000 after acquiring an additional 223 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Activity

In related news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares of the company’s stock, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.10% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on EHC shares. Barclays raised their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. UBS Group raised their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Zacks Research upgraded Encompass Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. Wall Street Zen cut Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Finally, KeyCorp lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 16th. Three analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average target price of $142.86.

Encompass Health Stock Performance

Shares of EHC opened at $111.73 on Thursday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm’s fifty day simple moving average is $121.85 and its two-hundred day simple moving average is $119.60. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.99. The stock has a market capitalization of $11.24 billion, a P/E ratio of 21.12, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The company had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s payout ratio is currently 14.37%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.